Text Size

A Clinical Evaluation of Wearing Surface in Total Hip Replacement

This study has been completed.
Sponsor:
Information provided by:
Frederiksberg University Hospital
ClinicalTrials.gov Identifier:
NCT00289692
First received: February 9, 2006
Last updated: November 26, 2007
Last verified: November 2007
History of Changes
  Purpose

Hip prosthesis will be evaluated at wearing and cytokines.


Condition Intervention Phase
THR
 Device: Total Hip Replacement
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label

Resource links provided by NLM:

MedlinePlus related topics: Hip Replacement
U.S. FDA Resources

Further study details as provided by Frederiksberg University Hospital:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • THR
  • Informed concent

Exclusion Criteria:

  • Osteoporosis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00289692

Sponsors and Collaborators
Frederiksberg University Hospital
Investigators
Principal Investigator: arne borgwardt, md Frederiksberg University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00289692     History of Changes
Other Study ID Numbers: KF 01-355/98
Study First Received: February 9, 2006
Last Updated: November 26, 2007
Health Authority: Denmark: Ethics Committee

ClinicalTrials.gov processed this record on June 18, 2013